Table 2 Antibiotic resistance in the ESBL E. coli group
Antibiotics | Sensitive | Intermediate | Resistant |
|---|---|---|---|
Ampicillin | 1 (2.5%) | 2 (5%) | 12 (30%) |
Gentamicin | 18 (45%) | 2 (5%) | 9 (22.5%) |
Piperacillin/Tazobactam | 4 (10%) | 9 (22.5%) | 16 (40%) |
Cefepime | 5(12.5%) | 1 (2.5%) | 15 (37.5%) |
Cefotaxime | 5 (12.5%) | 3 (7.5%) | 15 (37.5%) |
Ceftazidime | 7 (17.5%) | 3 (7.5%) | 12 (30%) |
Ciprofloxacin | 6 (15%) | 3 (7.5%) | 2 (5%) |
Meropenem | 19 (47.5%) | 3 (7.5%) | 1(2.5%) |
Trimethoprim/sulfamethoxazole | 4 (10%) | 3 (7.5%) | 2 (5%) |
Nitrofurantoin | 33 (82.5%) | 3 (7.5%) | 0 (0%) |
Clavulanic acid + Ceftazidime | 3 (7.5%) | 0 (0%) | 1(2.5%) |
Clavulanic acid + Cefotaxime | 3 (7.5%) | 0 (0%) | 1 (2.5%) |
Amikacin | 10 (25%) | 1 (2.5%) | 0 (0%) |
Oxacillin | 0 (0%) | 0 (0%) | 0 (0%) |
Norfloxacin | 1 (2.5%) | 1 (2.5%) | 4 (10%) |
Clindamycin | 1 (2.5%) | 0 (0%) | 2 (5%) |